• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英格兰伦敦一家医院收治的 COVID-19 患者发生重症的风险因素:一项回顾性队列研究。

Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study.

机构信息

Department of Infection, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.

Department of Acute Medicine, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.

出版信息

Epidemiol Infect. 2020 Oct 13;148:e251. doi: 10.1017/S0950268820002472.

DOI:10.1017/S0950268820002472
PMID:33046155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7591271/
Abstract

COVID-19 has caused a major global pandemic and necessitated unprecedented public health restrictions in almost every country. Understanding risk factors for severe disease in hospitalised patients is critical as the pandemic progresses. This observational cohort study aimed to characterise the independent associations between the clinical outcomes of hospitalised patients and their demographics, comorbidities, blood tests and bedside observations. All patients admitted to Northwick Park Hospital, London, UK between 12 March and 15 April 2020 with COVID-19 were retrospectively identified. The primary outcome was death. Associations were explored using Cox proportional hazards modelling. The study included 981 patients. The mortality rate was 36.0%. Age (adjusted hazard ratio (aHR) 1.53), respiratory disease (aHR 1.37), immunosuppression (aHR 2.23), respiratory rate (aHR 1.28), hypoxia (aHR 1.36), Glasgow Coma Scale <15 (aHR 1.92), urea (aHR 2.67), alkaline phosphatase (aHR 2.53), C-reactive protein (aHR 1.15), lactate (aHR 2.67), platelet count (aHR 0.77) and infiltrates on chest radiograph (aHR 1.89) were all associated with mortality. These important data will aid clinical risk stratification and provide direction for further research.

摘要

新型冠状病毒肺炎(COVID-19)在全球引发大流行,几乎每个国家都不得不采取前所未有的公共卫生限制措施。随着疫情的发展,了解住院患者发生重症的风险因素至关重要。本观察性队列研究旨在描述住院患者的临床结局与人口统计学特征、合并症、血液检查和床边观察之间的独立关联。在英国伦敦的 Northwick Park 医院,回顾性地确定了 2020 年 3 月 12 日至 4 月 15 日期间因 COVID-19 住院的所有患者。主要结局为死亡。使用 Cox 比例风险模型探索关联。本研究纳入了 981 例患者。死亡率为 36.0%。年龄(校正后风险比(aHR)1.53)、呼吸疾病(aHR 1.37)、免疫抑制(aHR 2.23)、呼吸频率(aHR 1.28)、缺氧(aHR 1.36)、格拉斯哥昏迷评分(GCS)<15(aHR 1.92)、尿素(aHR 2.67)、碱性磷酸酶(aHR 2.53)、C 反应蛋白(aHR 1.15)、乳酸(aHR 2.67)、血小板计数(aHR 0.77)和胸部 X 线浸润(aHR 1.89)均与死亡率相关。这些重要数据将有助于临床风险分层,并为进一步研究提供方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8b/7591271/75144075520f/S0950268820002472_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8b/7591271/f01bd8247c78/S0950268820002472_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8b/7591271/98b7e85d6b07/S0950268820002472_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8b/7591271/75144075520f/S0950268820002472_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8b/7591271/f01bd8247c78/S0950268820002472_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8b/7591271/98b7e85d6b07/S0950268820002472_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd8b/7591271/75144075520f/S0950268820002472_fig3.jpg

相似文献

1
Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study.英格兰伦敦一家医院收治的 COVID-19 患者发生重症的风险因素:一项回顾性队列研究。
Epidemiol Infect. 2020 Oct 13;148:e251. doi: 10.1017/S0950268820002472.
2
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.《纽约市 COVID-19 重症成人的流行病学、临床病程和结局:一项前瞻性队列研究》
Lancet. 2020 Jun 6;395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2. Epub 2020 May 19.
3
Deaths with COVID-19 and from all-causes following first-ever SARS-CoV-2 infection in individuals with preexisting mental disorders: A national cohort study from Czechia.首次感染 SARS-CoV-2 的伴有精神障碍的个体中 COVID-19 相关死亡和全因死亡:来自捷克的全国队列研究。
PLoS Med. 2024 Jul 15;21(7):e1004422. doi: 10.1371/journal.pmed.1004422. eCollection 2024 Jul.
4
Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.美国 10131 名 SARS-CoV-2 感染退伍军人住院、机械通气或死亡的危险因素。
JAMA Netw Open. 2020 Sep 1;3(9):e2022310. doi: 10.1001/jamanetworkopen.2020.22310.
5
Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople).医院获得性 COVID-19 感染:死亡率风险研究。COPE-医院获得性研究(老年人中的 COVID)。
J Hosp Infect. 2020 Oct;106(2):376-384. doi: 10.1016/j.jhin.2020.07.013. Epub 2020 Jul 21.
6
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征:前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
7
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study.COVID-19 患者在意大利疫情第一波期间住院治疗的 30 天死亡率:一项前瞻性队列研究。
Pharmacol Res. 2020 Aug;158:104931. doi: 10.1016/j.phrs.2020.104931. Epub 2020 May 22.
8
Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection.红细胞分布宽度与住院成人 SARS-CoV-2 感染患者死亡风险的关联。
JAMA Netw Open. 2020 Sep 1;3(9):e2022058. doi: 10.1001/jamanetworkopen.2020.22058.
9
New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.纽约市中心医院新冠肺炎的经历与当前数据:美国新冠疫情中心的回顾性分析
J Med Internet Res. 2020 Sep 18;22(9):e20548. doi: 10.2196/20548.
10
In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19.住院患者病死率与 COVID-19 住院的非酒精性脂肪性肝病患者的炎症反应相关。
PLoS One. 2020 Oct 8;15(10):e0240400. doi: 10.1371/journal.pone.0240400. eCollection 2020.

引用本文的文献

1
Were metabolic and other chronic diseases the driven onset epidemic forces of COVID-19 in Mexico?在墨西哥,代谢和其他慢性疾病是否是导致 COVID-19 大流行的主要原因?
Front Public Health. 2023 Aug 7;11:995602. doi: 10.3389/fpubh.2023.995602. eCollection 2023.
2
"Day 25": a temporal indicator of stabilization of mortality risk among COVID-19 patients with high viral load.“第25天”:病毒载量高的COVID-19患者死亡风险稳定的一个时间指标。
Trop Med Health. 2022 Dec 9;50(1):92. doi: 10.1186/s41182-022-00483-8.
3
Telemonitoring for COVID-19 positive pregnant women; feasibility and user experience of SAFE@home Corona: prospective pilot study.

本文引用的文献

1
Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID-19: experience from London.因 COVID-19 住院的免疫抑制患者的临床特征和结局:来自伦敦的经验。
J Intern Med. 2021 Mar;289(3):385-394. doi: 10.1111/joim.13172. Epub 2020 Sep 22.
2
Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes.COVID-19 流行病学:临床特征、危险因素和结局的系统评价和荟萃分析。
J Med Virol. 2021 Mar;93(3):1449-1458. doi: 10.1002/jmv.26424. Epub 2020 Aug 25.
3
Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis.
COVID-19 阳性孕妇远程监护;SAFE@home Corona 的可行性和用户体验:前瞻性试点研究。
BMC Pregnancy Childbirth. 2022 Jul 11;22(1):556. doi: 10.1186/s12884-022-04878-7.
4
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.研究2019冠状病毒病重症和死亡风险因素的研究中的异质性和偏倚风险:一项系统评价和荟萃分析
Pathogens. 2022 May 10;11(5):563. doi: 10.3390/pathogens11050563.
5
Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations.芬兰因 SARS-CoV-2 感染住院和死亡的预测因素:一项基于人群的登记研究及其对疫苗接种的意义。
Vaccine. 2022 May 26;40(24):3345-3355. doi: 10.1016/j.vaccine.2022.04.055. Epub 2022 Apr 22.
6
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis.COVID-19 合并 2 型糖尿病患者入院前使用降糖药物与死亡率的meta 分析
Metabolism. 2022 Jun;131:155196. doi: 10.1016/j.metabol.2022.155196. Epub 2022 Mar 31.
7
Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis.二甲双胍是否会影响新发或原有糖尿病的 COVID-19 患者的结局?一项系统评价和荟萃分析。
Br J Clin Pharmacol. 2022 Jun;88(6):2642-2656. doi: 10.1111/bcp.15258. Epub 2022 Feb 23.
8
ICU admission and mortality classifiers for COVID-19 patients based on subgroups of dynamically associated profiles across multiple timepoints.基于多个时间点动态关联特征亚组的 COVID-19 患者 ICU 入院和死亡率分类器。
Comput Biol Med. 2022 Feb;141:105176. doi: 10.1016/j.compbiomed.2021.105176. Epub 2021 Dec 27.
9
Hypoxia may be a determinative factor in COVID-19 progression.缺氧可能是新冠病毒疾病进展的一个决定性因素。
Curr Res Pharmacol Drug Discov. 2021;2:100030. doi: 10.1016/j.crphar.2021.100030. Epub 2021 May 9.
10
Improving the early identification of COVID-19 pneumonia: a narrative review.提高 COVID-19 肺炎的早期识别:叙述性综述。
BMJ Open Respir Res. 2021 Nov;8(1). doi: 10.1136/bmjresp-2021-000911.
基础呼吸系统疾病,特别是 COPD 和吸烟,与严重的 COVID-19 结局相关:系统评价和荟萃分析。
Respir Med. 2020 Sep;171:106096. doi: 10.1016/j.rmed.2020.106096. Epub 2020 Jul 30.
4
Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis.与 COVID-19 死亡相关的临床特征、实验室结局特征、合并症和并发症:系统评价和荟萃分析。
Aging Clin Exp Res. 2020 Sep;32(9):1869-1878. doi: 10.1007/s40520-020-01664-3. Epub 2020 Jul 30.
5
Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis.合并症与 2019 年冠状病毒病相关的严重或致命结局风险:系统评价和荟萃分析。
Int J Infect Dis. 2020 Oct;99:47-56. doi: 10.1016/j.ijid.2020.07.029. Epub 2020 Jul 25.
6
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
7
Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.新型冠状病毒病 2019(COVID-19)感染患者死亡的危险因素:观察性研究的系统评价和荟萃分析。
Aging Male. 2020 Dec;23(5):1416-1424. doi: 10.1080/13685538.2020.1774748. Epub 2020 Jun 8.
8
Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.2019年冠状病毒病(COVID-19)严重患者的淋巴细胞减少症:系统评价与荟萃分析
J Intensive Care. 2020 May 24;8:36. doi: 10.1186/s40560-020-00453-4. eCollection 2020.
9
Predictors for Severe COVID-19 Infection.预测 COVID-19 重症感染的因素。
Clin Infect Dis. 2020 Nov 5;71(8):1962-1968. doi: 10.1093/cid/ciaa674.
10
Hospitalization and Mortality among Black Patients and White Patients with Covid-19.新冠病毒感染住院患者的病死率:黑人和白人患者的比较。
N Engl J Med. 2020 Jun 25;382(26):2534-2543. doi: 10.1056/NEJMsa2011686. Epub 2020 May 27.